PCRX fundamentals
An in-depth look to Pacira BioSciences, Inc. operating, investing, and financing activities
PCRX free cash flow for Q3 24 is 49.83 M USD. For 2023, PCRX free cash flow was 139.49 M USD and operating cash flow was 154.65 M USD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM